Clinical trial
A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors
NCT03784677
Study timeline
Study start (actual)2019-07-29Date precision: day
Registry last updated2023-11-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Advanced Malignant Solid Neoplasmunresolved
Refractory Malignant Solid Neoplasmunresolved
Refractory Ovarian Carcinomaunresolved
Refractory Pancreatic Carcinomaunresolved
Stage II Pancreatic Cancer AJCC v8unresolved
Stage IIA Pancreatic Cancer AJCC v8unresolved
Stage IIB Pancreatic Cancer AJCC v8unresolved
Stage III Ovarian Cancer AJCC v8unresolved
Stage III Pancreatic Cancer AJCC v8unresolved
Stage III Prostate Cancer AJCC v8unresolved
Stage IIIA Ovarian Cancer AJCC v8unresolved
Stage IIIA Prostate Cancer AJCC v8unresolved
Stage IIIB Ovarian Cancer AJCC v8unresolved
Stage IIIB Prostate Cancer AJCC v8unresolved
Stage IIIC Ovarian Cancer AJCC v8unresolved
Stage IIIC Prostate Cancer AJCC v8unresolved
Stage IV Ovarian Cancer AJCC v8unresolved
Stage IV Pancreatic Cancer AJCC v8unresolved
Stage IV Prostate Cancer AJCC v8unresolved
Stage IVA Ovarian Cancer AJCC v8unresolved
Stage IVA Prostate Cancer AJCC v8unresolved
Stage IVB Ovarian Cancer AJCC v8unresolved
Stage IVB Prostate Cancer AJCC v8unresolved
Interventions
Sponsors & collaborators
M.D. Anderson Cancer Centerlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03784677 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.